Stay updated on Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.

Latest updates to the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page
- Check6 days agoChange DetectedNew study sites have been added across the US, Australia, and Canada, and some existing location sections have been removed. Page revision updated to v3.3.3.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.2 was deployed; the changes appear to be a software/UI update with no changes to study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedPublications notes are clarified to indicate entries are automatically filled from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.1 (previously v3.2.0).SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the temporary government funding status banner informing visitors about potential delays and operating status. Core study information, enrollment details, and trial results sections remain unchanged.SummaryDifference0.2%

- Check56 days agoChange DetectedThe new screenshot indicates a layout refresh with no changes to the core study details, eligibility criteria, or the locations listed. No substantive content was added or removed from the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.